FHLC Among Health Care ETFs
End-of-day Nov 13, 2026 · 33 Health care ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.4% | +2.0% | +5.8% | +11.1% | +22.4% | +24.5% | +56.9% | +45.0% | +333.1% |
| Peer average | −0.1% | +0.8% | +3.7% | +4.0% | +21.5% | +25.9% | +71.5% | +27.0% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$145 of every $1,000 in FHLC is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 14.54% | $1,453.87 | 418K | $601.3M |
| 2 | JNJJohnson & Johnson | Healthcare | 8.53% | $852.96 | 1.3M | $352.8M |
| 3 | ABBVAbbvie | Healthcare | 6.59% | $658.57 | 923K | $272.4M |
| 4 | UNHUnitedhealth Group | Healthcare | 4.62% | $462.40 | 475K | $191.2M |
| 5 | MRKMerck & NEW | Healthcare | 4.59% | $459.34 | 1.3M | $190.0M |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.37% | $337.03 | 194K | $139.4M |
| 7 | AMGNAmgen | Healthcare | 3.19% | $319.25 | 282K | $132.0M |
| 8 | GILDGilead Sciences | Healthcare | 2.66% | $266.29 | 649K | $110.1M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.41% | $240.55 | 910K | $99.5M |
| 10 | PFEPfizer | Healthcare | 2.12% | $212.10 | 3.0M | $87.7M |
| 11 | ISRGIntuitive Surgical | Healthcare | 2.01% | $201.18 | 185K | $83.2M |
| 12 | DHRDanaher | Healthcare | 1.89% | $189.40 | 333K | $78.3M |
| 13 | —Securities Lending CF | — | 1.83% | $182.80 | 75.6M | $75.6M |
| 14 | VRTXVertex Pharmaceuticals | Healthcare | 1.75% | $175.45 | 133K | $72.6M |
| 15 | 0Y6X.LMedtronic | Healthcare | 1.64% | $164.35 | 669K | $68.0M |
of the $114B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 14.54% |
| 2 | JNJ | Johnson & Johnson | 8.53% |
| 3 | ABBV | Abbvie | 6.59% |
| 4 | UNH | Unitedhealth Group | 4.62% |
| 5 | MRK | Merck & NEW | 4.59% |
| 6 | TMO | Thermo Fisher Scientific | 3.37% |
| 7 | AMGN | Amgen | 3.19% |
| 8 | GILD | Gilead Sciences | 2.66% |
| 9 | ABT | Abbott Laboratories | 2.41% |
| 10 | PFE | Pfizer | 2.12% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |